My watch list  

173 Current news about the topic patents


You can refine your search further. Select from the filter options on the left to narrow down your results.

Lavipharm acquires exclusive rights to Phasex supercritical fluids technology


Lavipharm Laboratories Inc. (East Windsor, NJ) announced on December 6 that it has acquired rights to Phasex Corp.'s (Boston) supercritical fluids (SCF) technology, patents, trademark, and know-how for use in the pharmaceutical and cosmetic fields, together with a 30% equity ...


MWG Biotech: Statement on the Chip Patent Situation


Affymetrix holds over 140 important patents for expression profiling, mutation analysis, genotyping and SNP analysis. Any company who wants to enter this market, be it for basic research, for the development of new medications, or for disease diagnostics, needs to acquire a licence from ...


MorphoSys receives first HuCAL Patent


Munich, Germany, October 31, 2000 MorphoSys AG (Neuer Markt: MOR) announced today that the Australian Patent Office has granted a patent covering its proprietary Human Combinatorial Antibody Library (HuCAL) technology. The patent covers the design and the methods of making the HuCAL antibody ...


Page 18 From 18
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE